Chinese CRO Alliance Sets Eyes On Europe
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - U.K.-based NovaSecta joined Sundia Meditech and HD Biosciences in China's first contract research organization alliance, the three companies announced Feb. 18
You may also be interested in...
China's Largest Science Park Aims To Double Pharma Output In Three Years; Launches New Partnering Platform
SHANGHAI - The pharmaceutical output of Shanghai Pudong area, where the Zhangjiang Hi-tech park is located, achieved RMB 12.7 billion ($1.85 billion) in 2008 and increased 13.1 percent compared to 2007, said Lin Benchun, the deputy chief of Shanghai Pudong Science and Technology Commission, during the China Pharmaceutical R&D Summit preconference April 6
China's Largest Science Park Aims To Double Pharma Output In Three Years; Launches New Partnering Platform
SHANGHAI - The pharmaceutical output of Shanghai Pudong area, where the Zhangjiang Hi-tech park is located, achieved RMB 12.7 billion ($1.85 billion) in 2008 and increased 13.1 percent compared to 2007, said Lin Benchun, the deputy chief of Shanghai Pudong Science and Technology Commission, during the China Pharmaceutical R&D Summit preconference April 6
AstraZeneca Outsources Drug Discovery Research To BioDuro For Respiratory And Inflammation Indications
SHANGHAI - AstraZeneca is expanding its research collaboration with contract research organization BioDuro to cooperate on drug discovery research in respiratory and inflammation diseases in China, the two companies announced March 23